medigraphic.com
SPANISH

Correo Científico Médico de Holguín

ISSN 1560-4381 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 3

<< Back Next >>

Correo Científico Médico 2017; 21 (3)

Type 1 Gaucher’s disease. Presentation of a case

Millán BR, Patiño PJM, Matos PMJ, Sanz PNJ, Reyes GO
Full text How to cite this article

Language: Spanish
References: 11
Page: 924-931
PDF size: 460.25 Kb.


Key words:

Gaucher's disease, glucocerebrosides, hepatosplenomegaly.

ABSTRACT

Gaucher disease is a rare autosomal recessive disorder due to the absence of the enzyme glucocerebrosidase, resulting in accumulation of glucocerebrosides in the endothelial reticulum system. It is manifested by hematic alterations, hepatosplenomegaly and neurological and bone manifestations. Cells that accumulate the glucocerebroside are called Gaucher cells. A 16-year-old white female patient of rural origin who came to Octavio de la Concepción y de La Pedraja Provincial Pediatric Hospital presenting anemia, decay and weight loss, was also accompanied by an increase in volume abdomen. With the history of presenting aseptic necrosis of the right femur and diabetic mother. Physical examination revealed the presence of large mucosal skin paleness, hepatosplenomegaly. The neurological examination was completely normal. Anemia and thrombocytopenia were found on the blood tests. Biopsy of the spleen, liver and bone marrow was performed with Gaucher cells. The diagnosis was made based on the clinic, with heavy presence of bone manifestations and hepatosplenomegaly. It was also based on histological observation of Gaucher cells and on the determination of low levels of glucocerebrosidase enzyme activity in blood leukocytes or cutaneous fibroblasts.


REFERENCES

  1. Kline AD, Calof AL, Schaaf CA, Krantz ID, Jyonouchi S, Yokomori K, et al. Cornelia de Lange syndrome: Further delineation of phenotype, cohesin biology and educational focus, 5th. Biennial Scientific and Educational Symposium abstracts. Am J Med Genet A. 2014[citado 20 oct 2016]; 164(6):1384-1393. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.36417/abstract;jsessionid=BBD8B16CFBB29A999D20F6B1BF96A518.f02t01

  2. Pavlidis E, Cantalupo G, Bianchi S, Piccolo B, Pisani F. Epileptic features in Cornelia de Lange syndrome: Case report and literature review. Brain Dev. 2014[citado 20 feb 2016]; 36(10): 837-843.Disponible en: http://www.sciencedirect.com/science/article/pii/S0387760413003513

  3. Dave U, Shetty D. Mutational Screening and Prenatal Diagnosis in Cornelia de Lange syndrome. J Obstet Gynaecol India. 2014[citado 20 feb 2016]; 64(1):27-31.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931894/

  4. Teresa Rodrigo ME, Eckhold J, Puisac B, Dalski A, Gil Rodríguez MC, Braunholz D, et al. Functional Characterization of NIPBL Physiological Splice Variants and Eight Splicing Mutations in Patients with Cornelia de Lange Syndrome. Int J Mol Sci. 2014[citado 30 nov 2016]; 15(6):10350-10364. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100155/

  5. Zuin J, Franke V, van Ijcken WF, van der Sloot A, Krantz ID, van der Reijden MI, et al. A cohesin-independent role for NIPBL at promoters provides insights in CdLS. PLoS Genet. 2014[citado 20 jun 2016]; 10(2):1004153.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923681/

  6. Kaiser FJ, Ansari M, Braunholz D, Gil Rodríguez MC, Decroos C, Wilde JJ, et al. Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance. Hum Mol Genet.2014 [citado 20 jun 2016]; 23(11): Disponible en: http://hmg.oxfordjournals.org/content/23/11/2888.long

  7. Barbero JL. Genetic basis of cohesinopathies. Appl Clin Genet. 2013[citado 20 feb 2016]; 6:15-23. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711096/

  8. Gervasini C, Parenti I, Picinelli C, Azzollini J, Masciadri M, Cereda A, et al. Molecular characterization of a mosaic NIPBL deletion in a Cornelia de Lange patient with severe phenotype. Eur J Med Genet. 2013[citado 20 feb 2016]; 56(3):138-143.Disponible en: http://www.sciencedirect.com/science/article/pii/S1769721213000037

  9. Marchisio P, Selicorni A, Bianchini S, Milani D, Baggi E, Cerutti M, et al. Audiological findings, genotype and clinical severity score in Cornelia de Lange syndrome. Int J Pediatr Otorhinolaryngol. 2014[citado 30 oct 2016]; 78(7):1045-1048. Disponible en: http://www.sciencedirect.com/science/article/pii/S0165587614001876

  10. Santana Hernández EE, Tamayo Chang VJ, Pupo Zalazar O. Síndrome de Cornelia de Lange. Presentación de un paciente. Medic Electrón. 2015[citado 23 nov 2016];19(4): 253-257. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432015000400008&lng=es

  11. Sanz H, Suárez E, Rodríguez S, Durán JP, Cortez V. Síndrome de cornelia de lange síndrome de brachmann de lange. Gac Med Boliviana .2007 [citado 23 nov 2016]; 30(2):54-57. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1012-29662007000200011&lng=es




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Correo Científico Médico. 2017;21